Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Cyclacel Pharmaceuticals Inc    CYCC   US23254L3069

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/11/2014 04/14/2014 04/15/2014 04/16/2014 04/17/2014 Date
3.5(c) 3.31(c) 3.23(c) 3.17(c) 3.28(c) Last
179 787 364 413 371 452 111 255 106 636 Volume
-1.96% -5.43% -2.42% -1.86% +3.47% Change
More quotes
Company
Cyclacel Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious diseases. Its most advance product candidate, is the subject of SEAMLESS, a phase 3 trail being... 
Surperformance© rating of Cyclacel Pharmaceuticals I
Trading Rating : Investor Rating : -
More about the company
Chart CYCLACEL PHARMACEUTICALS I
Duration : Period :
Cyclacel Pharmaceuticals I Technical Analysis Chart | CYCC | US23254L3069 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 0,15 M
EBIT 2014 -22,7 M
Net income 2014 -22,8 M
Debt 2014 -
Yield 2014 -
Sales 2015 0,23 M
EBIT 2015 -28,2 M
Net income 2015 -28,1 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 488x
Capi. / Sales 2015 326x
Capitalization 73,2 M
More Financials
Latest news on CYCLACEL PHARMACEUTICALS I
04/10 CYCLACEL PHARMACEUTICALS : Independent Investigators Present Non-Clinical Data P..
04/09 CYCLACEL PHARMACEUTICALS : Announces Closing of $10 Million Underwritten Offerin..
04/04 CYCLACEL PHARMACEUTICALS : Entry into a Material Definitive Agreement, Other Eve..
04/04 CYCLACEL PHARMACEUTICALS : Announces $10 Million Underwritten Offering
04/03 CYCLACEL PHARMACEUTICALS : Announces Proposed Public Offering of Common Stock
03/25 CYCLACEL PHARMACEUTICALS : Results of Operations and Financial Condition, Financ..
03/25 CYCLACEL PHARMACEUTICALS : Reports Fourth Quarter and Full Year 2013 Financial R..
03/21 CYCLACEL PHARMACEUTICALS : Change in Directors or Principal Officers, Other Even..
03/13 CYCLACEL PHARMACEUTICALS : to Release Fourth Quarter and Full Year 2013 Financia..
03/05 CYCLACEL PHARMACEUTICALS INC : BioNJ Targets Streamlined Therapeutic Development..
02/28 CYCLACEL PHARMACEUTICALS INC : BioNJ Rolls Out Clinical Trials Master Service Ag..
02/03 CYCLACEL PHARMACEUTICALS INC : Cyclacel Pharmaceuticals to Present at the 16th A..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Technical analysis
Income Statement Evolution
Cyclacel Pharmaceuticals I : Income Statement Evolution
More Financials
EPS Revisions
Cyclacel Pharmaceuticals I : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF